Literature DB >> 34249422

IL-17 signaling pathway plays a key role in laryngeal squamous cell carcinoma with ethnic specificity.

Li Qi1, Wenzhao Bao2, Wei Li1, Xiaoxu Ding1, Aihui Yan1.   

Abstract

Laryngeal squamous cell carcinoma (LSCC) is a common aggressive head and neck squamous cell carcinoma (HNSCC) and racial disparities have been reported to exist in it. However, its molecular mechanism and associated ethnic specificity are still unclear. Here, we leveraged mRNA expression data from 2 gene expression omnibus datasets (GSE142083 & GSE117005) of Chinese samples and the cancer genome atlas (TCGA) datasets of Caucasian samples to demonstrate the expression signature of LSCC. The GSE142083 dataset was used as the discovery set since it had 53 pairs of LSCC tissues and matched adjacent normal tissues, and the GSE117005 dataset was treated as the validation set with 5 pairs of tissues. Differential gene expression analysis and enrichment pathway analysis were performed. Besides, we employed weighted gene co-expression network analysis to identify hub genes in validated pathways. The TCGA datasets were used to evaluate ethnic specificity. Immunohistochemistry (IHC) was employed to further validate the hub gene. Overall, the IL-17 signaling pathway was significantly enriched for upregulated genes in two Chinese datasets while not in TCGA datasets; and IL17RC, MAPK3, S100A8, MMP3, CXCL8, and TNFA1P3 were hub genes regulating such pathway. Therein, IL17RC might be the most important one and the IHC results displayed that the IL17RC gene upregulated in the LSCC tissue. IL-17 signaling pathway has an ethnicity-specific effect in LSCC where it is upregulated in the Chinese while not in the Caucasians and IL17RC might play a key role. Targeting genes located in the IL-17 signaling pathway may be beneficial for Chinese LSCC patients. AJCR
Copyright © 2021.

Entities:  

Keywords:  IL-17 signaling pathways; Laryngeal squamous cell carcinoma; ethnic specificity; gene expression

Year:  2021        PMID: 34249422      PMCID: PMC8263688     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  33 in total

1.  Identification of biomarkers with a tumor stage-dependent expression and exploration of the mechanism involved in laryngeal squamous cell carcinoma.

Authors:  Lian Hui; Ning Yang; Huijun Yang; Xing Guo; Xuejun Jang
Journal:  Oncol Rep       Date:  2015-08-27       Impact factor: 3.906

2.  Organ preservation for advanced larynx cancer: A review of chemotherapy and radiation combination strategies.

Authors:  Marcelo R Bonomi; Adriana Blakaj; Dukagjin Blakaj
Journal:  Oral Oncol       Date:  2018-10-13       Impact factor: 5.337

3.  Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population.

Authors:  Qingyi Wei; Dianke Yu; Mingbo Liu; Mengyun Wang; Miaoqing Zhao; Ming Liu; Weihua Jia; Hongxia Ma; Jugao Fang; Wei Xu; Kexing Chen; Zhengang Xu; Jialing Wang; Linli Tian; Hua Yuan; Jiang Chang; Zhibin Hu; Lixun Wei; Ying Huang; Yaling Han; Jie Liu; Demin Han; Hongbing Shen; Shiming Yang; Hong Zheng; Qinghai Ji; Duanshu Li; Wen Tan; Chen Wu; Dongxin Lin
Journal:  Nat Genet       Date:  2014-09-07       Impact factor: 38.330

4.  Th17 expression and IL-17 levels in laryngeal squamous cell carcinoma patients.

Authors:  Fu-Jun Li; Zhi-Jian Cai; Fei Yang; Shou-De Zhang; Ming Chen
Journal:  Acta Otolaryngol       Date:  2016-01-12       Impact factor: 1.494

Review 5.  An update on larynx cancer.

Authors:  Conor E Steuer; Mark El-Deiry; Jason R Parks; Kristin A Higgins; Nabil F Saba
Journal:  CA Cancer J Clin       Date:  2016-11-29       Impact factor: 508.702

6.  Carcinoma cell-derived chemokines and their presence in oral fluid.

Authors:  Katleen Michiels; Evemie Schutyser; René Conings; Jean-Pierre Lenaerts; Willy Put; Sandra Nuyts; Pierre Delaere; Reinhilde Jacobs; Sofie Struyf; Paul Proost; Jo Van Damme
Journal:  Eur J Oral Sci       Date:  2009-08       Impact factor: 2.612

Review 7.  IL-17 receptor-based signaling and implications for disease.

Authors:  Xiaoxia Li; Rami Bechara; Junjie Zhao; Mandy J McGeachy; Sarah L Gaffen
Journal:  Nat Immunol       Date:  2019-11-19       Impact factor: 25.606

8.  KEGG: new perspectives on genomes, pathways, diseases and drugs.

Authors:  Minoru Kanehisa; Miho Furumichi; Mao Tanabe; Yoko Sato; Kanae Morishima
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

9.  The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).

Authors:  Ezra E W Cohen; R Bryan Bell; Carlo B Bifulco; Barbara Burtness; Maura L Gillison; Kevin J Harrington; Quynh-Thu Le; Nancy Y Lee; Rom Leidner; Rebecca L Lewis; Lisa Licitra; Hisham Mehanna; Loren K Mell; Adam Raben; Andrew G Sikora; Ravindra Uppaluri; Fernanda Whitworth; Dan P Zandberg; Robert L Ferris
Journal:  J Immunother Cancer       Date:  2019-07-15       Impact factor: 13.751

10.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

View more
  3 in total

1.  Integrated Analysis Reveals S100a8/a9 Regulates Autophagy and Apoptosis through the MAPK and PI3K-AKT Signaling Pathway in the Early Stage of Myocardial Infarction.

Authors:  Weijue Yi; Rongli Zhu; Xiuyang Hou; Fengmin Wu; Rui Feng
Journal:  Cells       Date:  2022-06-13       Impact factor: 7.666

2.  Prognostic biomarker IL17A correlated with immune infiltrates in head and neck cancer.

Authors:  Meng Yu; Xing Xing Qian; Guang Li; Zexing Cheng; Zhijie Lin
Journal:  World J Surg Oncol       Date:  2022-07-28       Impact factor: 3.253

3.  Network Pharmacology-Integrated Molecular Docking Reveals the Expected Anticancer Mechanism of Picrorhizae Rhizoma Extract.

Authors:  Xiaomeng Hu; Shengchao Zhao; Yi Cai; Shasank S Swain; Liangliang Yao; Wei Liu; Tingdong Yan
Journal:  Biomed Res Int       Date:  2022-09-16       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.